Myeloproliferative diseases

MYELOPROF

No definition available.

Endpoint definition

FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector

Filter registries None

0

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

0

diagram downward connector

Check minimum number of events None

0

diagram downward connector
MYELOPROF

Extra metadata

First used in FinnGen datafreeze DF2, additional

Summary Statistics

Key figures

All Female Male
Number of individuals 1921 992 929
Unadjusted prevalence (%) 0.54 0.50 0.59
Mean age at first event (years) 61.01 60.08 62.01

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.06 3.38 [2.14, 5.34] 1.9e-7 375
15 years 0.01 1.91 [1.32, 2.77] 6.1e-4 174
5 years 0.00 3.22 [2.37, 4.37] 6.6e-14 105
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: MYELOPROF – Myeloproliferative diseases
GWS hits:

Survival analyses between endpoints

Plot

before Myeloproliferative diseases
after Myeloproliferative diseases

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Myeloproliferative diseases